Trial record 1 of 2 for:    Atezolizumab and daratumumab
Previous Study | Return to List | Next Study

A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (DARZALEX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03023423
Recruitment Status : Recruiting
First Posted : January 18, 2017
Last Update Posted : March 2, 2018
Genentech, Inc.
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 25, 2018
  Estimated Study Completion Date : October 16, 2020